Month: February 2023

HOUSTON, Feb. 28, 2023 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced its operating and financial results for the fourth quarter and full year of 2022. Whitestone creates neighborhood center communities in its high-quality open-air shopping centers that it acquires, owns, manages, develops, and redevelops primarily in the largest, fastest-growing, high-household-income markets in the Sunbelt. “2022 was an outstanding year of achievement for Whitestone.  We grew occupancy by 240 basis points to a record 93.7%.  Same store NOI was up 7.9%.  We grew FFO/share by nearly 20% and reduced our debt/EBITDAre by 1.3x, down to 7.8x. We amended and extended our credit facility and subsequently received an investment grade credit rating.  Our tenants and our centers continue to thrive, and we...

Q4 and FY 2022 Gross Merchandise Value Increased Year-Over-Year 13% and 23%, respectivelyQ4 and FY 2022 Total Revenue Increased Year-Over-Year 10% and 29%, respectivelyCash & Cash Equivalents at Year-End was $294 million SAN FRANCISCO, Feb. 28, 2023 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today reported financial results for its fourth quarter and full year ended December 31, 2022. Fourth quarter and full year 2022 gross merchandise value (GMV) increased 13% and 23%, respectively, compared to the same periods in 2021. “We are pleased to announce solid financial results for the fourth quarter and full year 2022, including improved gross profit and Adjusted EBITDA loss on a year-over-year basis,” said Rati Levesque, President and Chief Operating...

PALO ALTO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) — HP (NYSE: HPQ)First quarter GAAP diluted net earnings per share (“EPS”) of $0.49, within the previously provided outlook of $0.47 to $0.57 per share First quarter non-GAAP diluted net EPS of $0.75, within the previously provided outlook of $0.70 to $0.80 per share First quarter net revenue of $13.8 billion, down 18.8% from the prior-year period First quarter net cash used in operating activities of $(16) million, free cash flow of $(0.2) billion First quarter returned $0.4 billion to shareholders in the form of share repurchases and dividendsHP Inc.’s fiscal 2023 first quarter financial performance                    Q1 FY23     Q1 FY22   Y/Y  GAAP net revenue ($B) $ 13.8   $ 17.0   (18.8)%  GAAP operating margin   5.5%     8.0%   (2.5) pts  GAAP...

ROCK HILL, S.C., Feb. 28, 2023 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter Financial Results and Recent Business Highlights (All numbers are unaudited and are presented in thousands, except per share amounts or otherwise noted)Q4 2022 revenue of $132,732 decreased 12.0% compared to Q4 2021; Non-GAAP Q4 2022 revenue on a constant currency basis(1) decreased 7.6%, reflecting weakness in the dental orthodontics market Net loss of $25,553, diluted loss per share of $0.20, and diluted non-GAAP loss per share of $0.06 (1) Negative adjusted EBITDA(1) of $4,808 reflects inflationary impacts on our input costs, unfavorable product mix, and continued investments in growth areas of our business and product portfolioFull...

eXp World Holdings Reports Q4 and Full-Year 2022 Results 2022 Revenue of $4.6 Billion, up 22% Year Over Year Segment Reporting Introduced Highlighting Profitable Q4 in North American RealtyCompany Declares Cash Dividend for Q1 2023 of $0.045 per Share of Common StockGlenn Sanford Returns as CEO of eXp Realty to Drive Next Phase of Agent-Centric Growth2022 Revenue of $4.6 Billion, up 22% Year Over Year Segment Reporting Introduced Highlighting Profitable Q4 in North American Realty Company Declares Cash Dividend for Q1 2023 of $0.045 per Share of Common Stock Glenn Sanford Returns as CEO of eXp Realty to Drive Next Phase of Agent-Centric Growth BELLINGHAM, Wash., Feb. 28, 2023 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), (or the “Company”), the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises,...

— Record Fourth Quarter Net Sales Rise 6.2 Percent to $1.51 Billion —— Net Sales, Adjusted for Adverse Changes in Foreign Currency of $81.9 Million, Rise 11.9 Percent —— Gross Margin Percentage Increases on a Quarterly Sequential Basis —— Company Declares Two-for-One Stock Split — CORONA, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ: MNST) today reported financial results for the three- and twelve-months ended December 31, 2022. The Company achieved record fourth quarter net sales of $1.51 billion for the 2022 fourth quarter, 6.2 percent higher than net sales for the 2021 comparable period. Net changes in foreign currency exchange rates had an unfavorable impact on net sales for the 2022 fourth quarter of $81.9 million. Net sales on a foreign currency...

Revenues from continuing operations were $630.4 million, up marginally, and up 8.1% on an organic constant currency (OCC) basis for the fourth quarter of 2022. Our revenue from continuing operations growth was flat primarily due to the sale of our environmental health and safety business (“3E”) and Financial Services segment. Income from continuing operations was $215.8 million, up 82.4% for the fourth quarter of 2022.  Adjusted EBITDA, a non-GAAP measure, was $332.0 million, up 4.1%, and up 12.9% on an OCC basis. The increase in income from continuing operations is primarily due to an impairment loss incurred in 2021 related to the disposition of our Financial Services segment, offset by a reversal of a litigation reserve.   Diluted GAAP earnings per share from continuing operations (diluted EPS) were $1.37 for the fourth...

Financial results and business update call scheduled for 5:00 p.m. ET today LOUISVILLE, Colo., Feb. 28, 2023 (GLOBE NEWSWIRE) — Solid Power, Inc. (Nasdaq: SLDP), a developer of solid state battery technology, today announced its financial results for the full year ended December 31, 2022. Recent Business HighlightsElectrolyte production facility on track to be commissioned in the first quarter of 2023. EV cell production began in fourth quarter, with initial EV cells expected to be delivered to partners in 2023. Deliveries of 20 Ah cells are ongoing. Deepened relationship with BMW through expanded joint development agreement. Secured Department of Energy funding to continue the development of Solid Power’s nickel- and cobalt-free cell.“I am extremely proud of our team’s hard work and unwavering dedication moving the company...

– Revenue Nearly Doubled Year-Over-Year to $94.7 million – – System Solutions Revenue Increased 150% Year-Over-Year – – Gross Margin Expanded More Than 950 bps Year-Over-Year – – Backlog and Awarded Orders Up 43% Year-Over-Year to $428.6 million – – Provides 2023 Outlook for Continued Strong Growth – PORTLAND, Tenn., Feb. 28, 2023 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance of system (“EBOS”) solutions for solar, battery storage and electric vehicle charging infrastructure, today announced results for its fourth quarter and full year ended December 31, 2022. “Shoals set new records for revenue, gross profit, net income, adjusted EBITDA and adjusted net income in both the fourth quarter and full year. Compared to the prior-year periods, fourth...

Paltusotine’s Phase 3 PATHFNDR-1 study enrollment complete and topline data expected in 3Q 2023Paltusotine’s Phase 3 PATHFNDR-2 study enrollment ongoing with topline data now expected in 1Q 2024Pending a successful outcome from the PATHFNDR studies, an NDA submission in acromegaly is expected in 2024Paltusotine’s Phase 2 study in carcinoid syndrome on track for data in 2H 2023CRN04894’s studies in Cushing’s disease and congenital adrenal hyperplasia commenced in 1Q 2023SAN DIEGO, Feb. 28, 2023 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today reported financial results for the fourth quarter and year ended December 31, 2022. “We continue to make great progress in our vision to build a premier, fully integrated endocrine company that can sustainably innovate pioneering therapies for our patients...